[Azathioprine].
Sasaki
Masaya
M
Department of Gastroenterology, Shiga University of Medical Science.
Fujiyama
Yoshihide
Y
D017209:Apoptosis; D001379:Azathioprine / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D018106:CD28 Antigens; D003093:Colitis, Ulcerative / Q000188:drug therapy; D003424:Crohn Disease / Q000188:drug therapy; D004359:Drug Therapy, Combination; D006086:Graft vs Host Disease / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D015122:Mercaptopurine / Q000031:analogs & derivatives / Q000378:metabolism; D015201:Meta-Analysis as Topic; D009696:Nucleic Acids / Q000378:metabolism; D011355:Prodrugs; D016032:Randomized Controlled Trials as Topic; D013601:T-Lymphocytes
D018106:CD28 Antigens; D007166:Immunosuppressive Agents; D009696:Nucleic Acids; D011355:Prodrugs; D015122:Mercaptopurine; D001379:Azathioprine